Organisation paid for research Program year 2025 Source: CMS Open Payments

The Urology Group PC

Neither a doctor nor a teaching hospital

Research payments

$216,941

18 payments

Through program year 2025, The Urology Group PC is reported as receiving $216,941 in research payments, across 18 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$28,773	3
2024	Research	$2,530	2
2023	Research	$173,661	5
2022	Research	$611	1
2021	Research	$1,554	1
2020	Research	$8,683	5
2019	Research	$1,129	1

Breakdown

Who paid Research payments · program years 2019–2025

Myriad Genetic Laboratories, Inc. $202,434 8 payments
Dendreon Pharmaceuticals LLC $14,507 10 payments

Studies the money was for Research payments · program years 2019–2025

Uro-013 $202,434 8 payments
Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer (Provent) $8,683 5 payments
A Randomized Phase 3, Open-Label Trial of Sipuleucel-T Administered to Patients on Active Surveillance for Newly Diagnosed Prostate Cancer $4,695 4 payments
Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer Provent $1,129 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.